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Introduction
"We believe that the rising cost of health care represents perhaps the most significant threat to the longterm economic secnrity of workers and retirees."
So reads the opening words of the aptly titled report by the Social Security Advisory Board, "The
Unsustainable Costs ofHealth Care, 2009."

Since the time of that report, Obamacare, ne The Patient Protection and Affordable Care Act, has
been signed into law, with far reaching implications for every sector of the U.S. health care system, both
public and private. However, despite significant cost control measures within the law, its primary focus
was on ensuring near universal access to health insurance. As a result, there remains much work to be
done in the realm of health policy to achieve sustainable cost controls, despite enormous progress.
In this paper, I hope to make a contribution towards helping policy makers craft a law to address

the challenges of cost inflation. I shall begin by examining the current state of health care expenditures in
detail, including distribution, outcomes, and, most importantly, cost trends and projections. Unless
otherwise noted, figures are totals for the entire country, not just the govenunent or private sector.
Next, the drivers of health care inflation will be analyzed, including areas of waste within the
system. This in turn will guide the discussion of policy solutions that might address the problem of health
care inflation. Different solutions will be evaluated by way of a cost benefit analysis involving fmancial,
political, and technical considerations.
Once a recommended policy option has been identified, I shall explore the implementation of
such a solution, considering both the steps that would need to be taken, as well as the potential pitfalls
that could ensue. In the end, I hope to produce a clear policy recommendation, properly contextualized, to
address key elements of the problem of health care inflation, as well as a road map for execution for
consideration by policymakers.
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I.

Current State of Health Care Inflation

In this section, I will examine the nature of health care cost inflation throughout the United States. There
is no single method by which to measure health care costs. In order to be as comprehensive as possible, I
will consider absolute spending, per capita spending, spending as a percentage of GDP, and international
cornpansons.

Before I delve into health care cost growth, I will consider the U.S. health care system in general.

In 2012, the most recent year where full data are available, the country spent $2.793 trillion on health
care. Of this, the largest individual component was hospitals, corning in at $882 billion. After that,
physicians and medical practitioners consume $752 billion, and prescription drugs account for $263
billion. A full breakdown is shown below (Martin, eta!. 2014).

Figure I. Health Care Spending Components, 20 12

2012 Health Care Components, Percent of Total
Spending
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II Precription Drugs
11 Medical Equipment
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Net cost of insurance
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Data from Center for Medicare and Medicaid Services
Leading the pack in terms of growth since, there are non-durable medical equipment, horne health
care, and hospitals. The total spent on these items have increased by 5.6%, 5.1 %, and 4.9%, respectively,
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between 2011 and 2012. These three categories have also had elevated growth rates over the five year
period leading up to 2012 (Martin, eta!. 2014).
It is also worth looking at how this spending is funded. While it is true that $328 billion a year is

paid by Americans on out-of -pocket care, the vast majority of health care spending, over two trillion
dollars, comes from insurance, both public or private (Martin, eta!. 2014).
fu 2012, 84.6% of Americans had some form of health insurance, and 15.4% were uninsured. Of
those with insurance, 63.9% had a private sector plan, and 32.6% had some form of government
coverage. It is worth noting that there is some overlap between the two groups (DeNavas-Walt, Proctor
and Smith 2013).
A majority of Americans received insurance through their employers, 54.9% in total. Only 9.8%
purchase their health insurance directly on the private market, although this will likely increase in the
coming years due to the health care exchanges established by the A CA. fudeed, over two million people
enrolled in private health insurance plans through the ACA in the last quarter of 2013 alone (Park,
Watkins and Andrews 2014).
Fignre 2. Health fusurance Providers

U.S. Health Insurance by Provider Market Share
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• Other health insurance

Data from Center for Medicare and Medicaid Services
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Of the total health care insurance system, $1.1 trillion is spent by the government on health
insurance each year. To break down by program, 28% of all health insurance spending goes to Medicare,
21% goes to Medicaid (split roughly equally between federal and state governments), and about 5% are
spent on other health insurance programs, primarily Children's Health Insurance Program (CHIP), and
military health care plans. All told, government comprise 54% of health insurance spending, and the
private market accounts for $917 billion, or 46% (Martin, et al. 2014).
Any way it is measured, health care spending has soared. Though it does not give the full picture,
the absolute level of spending is striking. Over the last eight decades, national health expenditures across
the entire economy have grown 60-fold in non-inflation adjusted dollars. Adjusting for inflation, it has
more than sextupled. This growth has been as consistent as it has been large: in all but 7 of the last 80
years, medical cost growth has outstripped GDP growth in the economy. At times, it has been by as much
as six percentage points, averaging more than double the rate of economic growth (Conover 2012).
Unfortunately, costs are poised to rise only further in the corning years.
Figure 3. Total Health Care Expenditures

U.S. health care spending 1970-2021, in billions
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In the last decade, from 2000 to 2010, spending virtually doubled, surging from $1.3 trillion

($800 billion inflation adjusted) to $2.6 trillion ($1.2 inflation adjusted). In the decade to follow, it is
projected to nearly double again, reaching $4.8 trillion by 2021 (CMS 2012). These are just gross
numbers, and they are not adjusted for inflation, but alternative measures of spending provide are hardly
more encouraging.
As with overall spending, per capita expenditures have doubled between 2000 and 2010, from
$4,880 ($2,800 inflation adjusted) per person, all the way up to $8,400 ($3 ,900 inflation adjusted). Future
projections are even bleaker, as the rate of increase is expected by the Centers for Medicare & Medicaid
Services (CMS) to rise even faster between 2012 and 2021. In the last 80 years, inflation adjusted per
capita spending has risen by eight-fold (Conover 2012).

Figure 4. Per Capita Health Care Spending

U.S. per capita health care spending, 1970-2021
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Most troubling of all, the share of the economy devoted to health has seen a steady climb as well.
As a result, capital that might be better utilized in other sectors of the economy ends up being sunk in the
health care industry (International Monetary Fund 2012). So great is the misallocation of resources that a
mere 1.5 percentage point reduction in health care inflation would yield an estimated increase in the real
GDP by 2% in 2020, 8% in 2030, and 16% by 2040. Tiris translates to a nearly $10,000 boost to the
income of a typical family of four (Council of Economic Advisers 2009).

Figure 5. Spending as percentage of GDP

U.S. health care spending, as a %of GOP, 1970-2021
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Data from Center for Medicare & Medicaid Services, Bureau a/Economic Analysis,
and the International Monetary Fund

Since 1929, the share of the economy spent on health care has quadrupled (Conover 2012).
Growth has not been perfectly uniform. Because the economy and health care spending grow at different
rates, the graph is not a straight line. For example, the recessions in 2001 and 2008 depressed GDP
growth concededly, but health care spending growth was not nearly as dampened. The result is that during
those periods, health care shot up as a percentage of GDP.
Today, this means that medical care consumes nearly one-fifth of GDP, an alarming figure. Far
more frightening, a 75 year projection of costs found that by 2082, one half of the entire economy will be
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for health care (P. Orszag 2008). Though it must be noted the analysis was performed before Obamacare
was implemented; furthermore, even the best analysts cannot penetrate the fog of such a distant future
with a great degree of clarity.
More recently, in 2012, the CBO has estimated in a 25-year baseline forecast that health care
spending will account for one-quarter of GDP by 2037, and it is expected to rise thereafter. Using an
alternative fiscal scenario- which assumed that by 2013 Congress would renew individual tax cuts (it
did) and prevent cuts to Medicare physician reimbursement (it did) -the numbers are even higher.
Additionally, the share of government spending devoted health care is projected to double by 2037. Were
this to occur, health care would account for roughly half of all federal spending. (CBO 2012).
Moving on to an international perspective, health care spending in the United States is also high
when compared against other developed nations, according to the Organization for Economic
Cooperation and Development (OECD). As noted above, the U.S. spends roughly $2.6 trillion and 18%
of GDP on health- more than any other developed nation in the world. For comparison, the next highest
is the Netherlands, which spends 12% of GDP, and the rest of the world is downhill from there (OECD
2012).
Figure 6. OECD Health Expenditures, as a Percentage of GDP
%GOP
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All the more troubling is the fact that, not only is the United States the world leader in health cost
expenditures, it is the leader in health care cost growth. Between 1980 and 2008, the share of GDP
devoted to health care rose 7 percentage points in the U.S., from 9% in 1980 to 16% in 2008. For the rest
of the developed world, the average was 2.7 percentage points of growth (Chandra and Skinner 2011).

Figure 7. OECD Health Expenditures for 1980 and 2008
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As can be seen using virtually any measure of health care spending- gross, per capita, GDP, and
international comparisons- they all point in the same direction: up. The concerns raised by these numbers
and trends are not simply academic; they have real impacts upon the wellbeing of the nation and its
people.
The Director of the Congressional Budget Office has said that "growth in [health care] spending
remains the central challenge in putting the federal budget on a sustainable path (Ehnenddorf 2013)."
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Indeed, because such a substantial portion of gove=ent spending is devoted to health care, when the
latter increases, so does the former.
On a more positive note, if increasing health care spending swells the deficit, the reverse is also
true. A mere 1.5 percentage point reduction in health care inflation has been estimated to reduce the
deficit by more than 6% of GDP by 2040. Even a 0.5 percentage point drop would result in the deficit
shrinking by 2% (Council of Economic Advisers 2009).
Medicare and Medicaid, the two largest gove=ent health insurance programs, are expected to
cost more than $10 trillion over the next decade (Elmenddorf2013), but if costs continue to climb
unabated, the programs run the risk ofbecoming strained. In 2011, the Medicare trust fund had $246
billion in its coffers, but under cunent law, it is expected to fall to $68 billion by 2022, and become
depleted by the mid-2020s. Were this to happen, beneficiaries would only be able to receive payments
equal to revenues collected for the program by payroll taxes, resulting in an all but certain reduction in
care (CBO 2012).
A reduction in overall health care costs has the potential of reducing gove=ent expenditures,
private insurance premiums and private out-of-pocket expenditures. Projected health care costs are the
leading factor in calculating private insurance premiums, resulting in very high costs of coverage (Health
Reserach Institute 2012). To put it in tangible terms, a family health insurance plan costs nearly $16,000,
a hospital admission will total almost $15,000, an average surgery runs $27,000, and an outpatient
hospital visit is $2,200 (Health Care Cost Institute 201 0). All told, deductibles and out-of-pocket expenses
have tripled over the last five years for insured patients (IMS Institute for Healthcare Informatics 20 13).
Even small reductions in health care spending can yield notable savings for families and for employers in
the form of insurance premiums. If health care cost growth was reduced by approximately one percentage
point, over the course of a decade, the average person would save $1,400 (Executive Office of the
President 20 13).
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Health care related expenses account for just over one-fifth of the average family's budget; a
greater percentage than any single category besides housing (Conover 2012). Historically, this is greatest
share in the last century, as long as the government has been recording such figures. In 1919, health care
consumed 3.7% of the family budget, but increased dramatically over the succeeding decades, up to
21.8% in 2010 (Johnson, Rogers and Tan 2001). Recalling Figure 4, which showed inflation-adjusted, per
capita health care spending double between the 1990s and 2010, it is not surprising that the share of the
budget devoted to health care doubled as well.
Figure 8. Health Care and the Family Budget

Health Care Spending as a Percentage of the Family
Budget for Select Years
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Employers also pay a price when health care costs rise. Although it is trending downwards, in
2011, a majority of Americans, 55.1 %, received their health insurance through employers. Among the
active labor force, it is over two-thirds, 68.2% (Janicki 2013). Consequentially, health care costs add a
great deal to the cost of business. Health care costs tack on $1,525 to every car that GM manufactures
(Volsky 2008), and Starbucks spends $300 million on employee health insurance; more than it does on

coffee beans (Lepore 2011).

11

On a positive note, when health care costs fall, and with them the cost of bringing on a new
employee, businesses can increase hiring. It has been posited that a ten percentage point reduction in
employer health insurance premiums could result in an increase in the share of working-age individuals
who are employed by 1.2 percentage points (Baicker and Chandra 2006).
High health care costs imperil health care decisions, for higher prices force people to cut back on
care. Indeed, more than a quarter of Americans have reported problems paying medical bills. Six in ten
have cut comers to try to manage costs, either foregoing or delaying care. This involves anything from
skipping a recommended treatment, failing to fill a prescription, or relying on home remedies (Kaiser
Public Opinion 2012).
Perhaps the most dramatically impacted group is retirees. Americans aged 66 and up spend
between 13%-16% of their income on medical care, a greater percentage than on food, transportation, or
miscellaneous (Kliff2013). Needless to say, a change in the cost of health care will have a profound
effect on one-sixth of their budget.
The American health care system has been radically transformed over the last half-century, from
Medicare to Obamacare, oftentimes to the great benefit of the public weal. However, these changes have
brought with them precipitous increases in costs. They not only inflate deficits, but also strain family
budgets and may even impinge upon the quality of care if treatment becomes prohibitively expensive. We
would do a disservice not only to ourselves, but to the next generation to meet these looming challenges
with inaction.
But before the financial meat ax is swung in reaction, it is important to have a firm understanding
of drivers ofhealth care costs. There can be no doubt that a great deal of health care spending is of the
utmost importance to countless Americans who rely on programs such as Medicare and Medicaid. To cut
indiscriminately would be to inflict grievous and perhaps unnecessary harm upon these families. I will
examine this issue in the next chapter.
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II.

Causes of Health Care Inflation

What is it that is driving the health care spending in America? There is no one cause of rising health care
costs across the nation. Rather, a number of forces work in concert to drive prices up. The most
significant factors are teclmology, income, insurance, and demographics. I will address each of them in

turn.
There is general consensus that teclmology is the largest factor. Medical teclmology is a broad
term that includes surgical procedures, diagnostic tests, drugs, prosthetics, and support systems (National
Center for Health Statistics 2009). While some technology provides life saving benefits; there are also
inefficiencies, and all of it is costly. A review of the literature by the CBO estimated that teclmology is
responsible for anywhere from 38 to 65 percent of health care cost growth (P. Orszag 2008), while a more
recent analysis found it to be between 27-48 percent. (Smith, Newhouse and Freeland 2009).
Teclmology also helps explain why the United States spends so much more than the rest of the
developed world. The U.S. tends to be an early adopter of medical technology, and ends up paying more
as a consequence (Conover 2012), which explains part of why the U.S. spends more than other developed
nations.
The higher prices of medical procedures, which persist even after a given teclmology enters into
the mainstream, are evident across a wide range of services, from a hip or knee replacement, to a coronary
bypass, to appendectomy, prices in the U.S. are about 50% higher than the rest of the developed world.
(OECD 2012). Lastly, it is worth noting that in 2012, durable medical equipment grew at a rate of 5.6%,
as compared to 3.7% for health care spending overall (Martin, eta!. 2014).
Moving on, health insurance, whether it is public insurance such as Medicare and Medicaid, or
private insurance paid by an employer inflates the costs of care. The reason for this is that insurance, be it
for health, property, or whatever else, distorts rational behavior. A patient insulated from the full costs of
care may request better, more expensive equipment, marginally beneficial procedures, or engage in riskier
13

behavior. The CBO approximated that it has accounted for 10-13% of health care growth, where Smith
Newhouse, aud Freeland peg it at about II%. (2009).
This is au area that may very well grow beyond the estimates, as they do not account for the
impact of the Affordable Care Act. Once it is fully implemented, it is projected to create an influx of22
million new patients with health insurance plans, aud the accompanying costs. This is expected to add two
to three percentage points of health care cost growth after its implementation (Walker 20 12).
While ACA may increase insurance costs, there may also be a countervailing force. Increasing
fmaucial pressure has prompted insurers to adopt greater use of co-payments and higher deductibles in
their plans. Since 2006, the percentage of workers with a plan that includes a general annual deductible
has increased from 52% to 72% (Rae, Panchal aud Claxton 2012). The percentage enrolled in a high
deductible piau increased from 4% to 10% since 2006 (GAO 2011). Thus, in the future, even insured
patients may have a greater incentive to reduce their spending.
The articles do not estimate the impact of this, but a separate study found that by adopting a high
deductible policy, spending was brought down by $527 person (Fronstin aud Roebuck 2013). Considering
that 10% of the population is already enrolled in a high deductible plan, aud the total population is 313
million, 281 million do not have high deductibles. If everyone switched to a high deductible plan aud
experienced similar cost savings to the Fronstin and Roebuck study, it would save $150 billion a year, or
about 5% of all spending.
The income effect is a well-documented economic phenomenon. As a people become wealthier,
they begin to purchase more goods and services, including consuming more health care services. There is
a wide deviation over what percentage of health care cost growth is attributable to this. The CBO puts it
anywhere from 5 to 23%, aud high-end estimates believe to be 28-43%.
Demographic changes and an aging population were not found to be au enormous factor, but a
notable one all the same. Most studies on the matter have found that aging only has a small effect in
14

health care spending growth, 8% or less according to the estimates (CBO 2012). It is also worth noting
that in the corning decade, a greater number of baby boomers will enter into retirement, and likely drive
up costs. Thus, future studies may ultimate increase the estimates for this category.
Surveying the underlying causes of health care spending illustrates the importance of targeting
cuts carefully. Technology, income, and insurance certainly increase costs, but one can hardly argue that
the nation would be made better off by reversing technological advancement, degrading incomes, and
slashing insurance coverage.

Figure 9. Percentage of Average Annual Growth in Real per Capita Health Spending Attributable to
Selected Factors
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But there may be a more fruitful way to reduce spending. By all accounts, a sizable share of
health care spending is unnecessary, that is to say, does not improve health outcomes. On the expansive
side, over $1 trillion may be spent on unnecessary care, nearly half of all expenditures
(PricewaterhouseCoopers 2008). Using more conservative estimates, there is $700 billion in waste, which
includes a variety of types of unnecessary spending, about a quarter oftotal spending (Whelan and Sekhar
2012).
Broadly speaking, the wasteful spending can be divided into six categories: administrative
complexity, lack of coordination, overtreatment, failures of delivery (prevention), fraud, and pricing
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failures. It is worth taking the time to understand each of them. Furthermore, to determine if each area is
truly a problem, I will consider whether the category is growing or is more prevalent in the U.S. as
compared to other developed nations.
Administrative complexity can generally be called overhead costs. It is inefficiency that occurs
within the health care system. Administrative costs account for anywhere from 3-13% of overall health
care expenditures (Schieber, et al. 2009), which equates to anywhere from $107 to 389 billion in wasteful
spending (Lallemand 2012). The health care sector spends more on administrative expenses as a share of
total costs than many other industries, such as manufacturing (Yong and Olsen 2010).
Of this total spent on administration, about 60% is from health care providers, and the remaining
40% is from insurers. To better contextualize the size of expenditures, it is double what the nation spends
on heart disease and three times it is spending on cancer (Cutler, Wikler and Basch 2012), the two leading
causes of death in the country.
The country also does not stack up favorably to international comparisons. A study by the Robert
Woods Johnson Foundation found that, per capita, the U.S. spent $1,059 on administrative costs for
health care services, as compared to $307 in Canada. It is estimated that if American physicians'
administrative costs were similar to their Canadian counterparts, there would be a savings of $27.6 billion
(Lallemand 2012).
Not only are the costs high; they have been consistently growing. Administrative expenses grew
at 7% annually between 1995 and 2005 according to the Congressional Budget Office. Between 2001 and
2010, they grew 107%, which is faster than overall health care spending, which grew 74% (Wikler, Basch
and Cutler 2012).
The cost can be measured in time as well as dollars. U.S. physicians spend, on average, 3.8 hours
a week interacting with payers -a total of three weeks lost over the course of a year. Furthermore, when
polled, nearly half of physicians said that time spent on this activity was "increasing a lot" (Yong and
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Olsen 2010). Moreover, nursing staff spends 21 hours a week on processing claims, while clerical staff
spends 47. Consequentially, health care providers employ more billing and posting clerks than any other
industry (Wilder, Basch and Cutler 20 12). Clearly, there is a great deal of waste within the system.
Lack of coordination between care providers can lead to a great deal of unnecessary medical
utilization. Two doctors may run the same test, a harmful treatment or drug may be prescribed because a
patient's medical history was not made readily available, and patients may be readmitted to a hospital for
avoidable reasons, or else put in the emergency room when the problem is less severe (R. Kelley 2009).
The sorts of errors that are caused by lack of coordination are more prevalent in the U.S. than in
many other developed countries. ill an international health survey by the Commonwealth Fund, the U.S
was found to have a higher rate of medical mistakes than any other country examined, and was above
average in being given the wrong medication (Mahon 2003).
Overtreatment is a broad term that includes treatments that provide little to no health benefit for
patients, the use of needlessly expensive technology, or care that is provided for some other reason than
the optimal health of the patient. The medical industry is replete with examples. For instance, $550
million is spent annually on antibiotics used to treat viral infections. However, as any high school biology
student would know, antibiotics are only effective against bacteria, not viruses (Whelan and Sekbar
2012). Even worse, certain procedures, such as vertebroplasty, an operation in which cement is injected to
stabilize the vertebrae, have evidence showing that are detrimental to patient health, but are prescribed
anyway (Chandra and Skinner 2011).
Although greater treatment is not definitive proof that care is wasteful, it is instructive to compare
the U.S. to the rest of the world. Americans receive three times as many MR1 scans as the OECD average,
and many more procedures per capita. For coronary artery bypass grafts, angioplasties, and stents, U.S.
patients, on average, receive 45% more than Norway, the next highest consumer ofthe procedures
(Swartz 2010).Given that the U.S. has worse health outcomes on many factors, it may point to the fact
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that care is unnecessary (Emanuel and Fuchs 2012). Of course, it may simply be that Americans need
more care, but these figures at least raise a suspicious eyebrow.
The largest sub-category of overtreatment is defensive medicine, which has been defined by the
now-defunct U.S. Office of Technology Assessment as "when doctors order tests, procedures, or visits, or
avoid high risk patients or procedures, primarily (but not necessarily solely) to reduce their exposure to
malpractice liability" (OTA 1994).
To begin with a brief introduction to the issue, the llledicalliability system works to diffuse the
fmancial risks that health care providers face from being sued by aggrieved patients. Doctors pay a
premium in order to purchase malpractice insurance. If they are found to be negligent in their treatment of
a patient and a lawsuit is ftled, the physician is protected against the full brunt of the litigation (Roberti
2012).
Parsing out the exact cost to the health care system from defensive medicine is notoriously
difficult. Doctors do not formally state which procedures are being done in whole or part to prevent a
lawsuit. As a result, numbers vary widely. However, estimates vary from $100 billion (R. Kelley 2009) to
$210 billion (Youn 2012). This translates into about 3-7% of total health care spending.
Failures of delivery are inefficiencies on health care providers' end, as well as failure to use best
practices in treatment. This also encompasses underuse of preventative care that would ultimately save
money on treatment in the long run (Berwick and Hackbarth 2012). The situation is not helped by the fact
that the current health care system has an incentive structure that rewards hospital and doctors for treating
chronic conditions over time, rather than preventing them from occurring.
Given that chronic diseases are a driver of failures of delivery, this category may well expand in
the future. As the baby boomers near retirement, the number and share of elderly patients will increase.
As a result, Medicare is projected to spend $189 billion on Alzheimer's disease by 2015, up from $91 in
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2005 (Swartz 201 0). Sirrrilarly, levels of spending for diabetes, lung disease, and heart disease are
expected to rise. This indicates that preventative care would bear increasingly large returns.
Fraud is intentional rrrisrepresentation that results in payment or overpayment for unnecessary or
non-existent treatment. Oftentimes, it is an attempt to bilk the government through Medicare and
Medicaid. It also includes the cost the government incurs from creating and implementing regulations to
prevent fraud from occurring (Lallemand 2012). The Government Accountability Office (GAO) has label
Medicare and Medicaid "high risk" in terms of being targets of fraud, and has noted that due to the ACA,
four rrrillion more will be added to the rolls of Medicaid in the next decade, meaning that fraud will likely

increase.
Lastly, pricing failures when there are distortions in a private market that result in the price
becoming excessively high. For example, many medical products in the U.S. are far more expensive than
in other developed countries. Barriers to a free market where goods are properly priced include lack of
adequate competition and opacity of health care product prices (Lallemand 2012).
Anecdotes of overpriced products are widely available. $50 disposable gloves (Rosenbaum
2013). $500 N bags (Bernstein 2013). $1,000 toothbrushes (Rosenberg 2013). The list goes on and on.
All of them are examples of patients, ignorant of the price of a good or service until after it has been
charged, who are unable to discern the actual value of their care. Of course, these are just isolated
examples; we may also look to more systematic variations in costs caused by pricing failures.
The average cost of a Medicare enrollee in Miarrri, the most expensive city, verses Honolulu, the
least expensive, was $16,000 and $5,300. One rrright assume that this was simply the result of aging
populations, but even spending in the last two years oflife showed a dramatic difference between the two
cities: $72,000 and $43,000 respectively (Schieber, et al. 2009).
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Figure 10. Total Cost to the U.S. Health Care System from Unnecessary Spending, in billions
Berwick and Hackbarth
{2012)

Kelley {2009)

Administrative Complexity

$107-389

$100-150

Lack of Coordination

$25-45

$25-50

Overtreatment

$158-226

$250-325

Failures of Delivery

$102-154

$100-150

Fraud

$82-272

$125-175

Pricing Failures

$84-131

-

Total

$558-1,263

$600-850

Taken together, these sources of unnecessary spending represent hundreds of billions of dollars of
waste. They are also the low hanging fruit in discussions over health care austerity, in the sense that,
although addressing each of these problems would provoke resistance from some groups, there would be
minimal harm inflicted upon beneficiaries.
But is there truly a pressing need to tackle these inefficiencies? The proceeding numbers may
paint a grim picture for the U.S. health care system, and yet, in 2012, Medicare and Medicaid posted
slower-than-expected growth in health care spending, producing savings in both programs {Montogmery
and Goldfarb 2013). Health care costs are projected to maintain a growth rate of 7.5% in 2013, consistent
with the last three years {S. Miller 2012). In terms of health care costs, this is comparatively low. This
prompts the question, what caused the dip?

Some of the equation is structural changes. This means that they will continue to exhibit an effect
on lowering costs due to shifts in the health care market. The professional consulting firm
PricewaterhouseCoopers has posited that the American health care system has entered a "new normal"
thanks to these changes {PricewaterhouseCoopers 2012).

There is certainly evidence to support the claim. The consolidation of hospitals has resulted in
economies of scale, meaning they can purchase supplies in bulk for a large number of physicians under
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their employ, rather than a myriad of practices purchasing materials individually. Additionally, merged
hospitals enjoy greater negotiating power to bargain for lower prices and may more readily utilize
inventory and tracking systems which allow them to monitor the usage of expensive equipment and make
more efficient decisions (Health Reserach Institute 20 12).

Greater usage of cheaper generic drugs has also helped dampen price increase. Over the last two
years alone, drugs representing $50 billion in sales went off patent (Health Reserach Institute 2012). As a
result, increase in spending on prescription drugs rose 0.4% in 2012, as compared to 2.5% the year before.
If this trend oflow cost growth continues, it will save several billion dollars a year (Martin, eta!. 2014).

Unfortunately, a large part of the lower cost equation is also cyclical. One of the few positive
economic impacts from a recession is lower inflation due to depressed spending. Over the last century,
inflation has averaged 3.3%. Since 2007, when the recession struck, it has been 2%, and only 1.7% in
2013 (Federal Reserve Bank of Minneapolis 20 13). As a result, prices across the economy fall, and
health care is no exception.

For example, supplies account for up to 40% of the costs of certain procedures. As prices of
supplies fall in a recession, the cost of treatment follows. Furthermore, spending cutbacks, both by the
government and consumers, creates an impetus for hospitals and other care providers to do more with
less. (PricewaterhouseCoopers 2012).

But while prices may fall, this is not necessarily something to celebrate. While it is true that
prices fall during a recession, so too do incomes. It may be that patients are simply putting off treatment
due to budgetary constraints, or families are reducing spending across the board to cope with turbulent
fmancial waters. Similarly, health care providers may simply be moving towards leaner, less expensive
plans, or requiring higher out-of-pocket payments, which would deter consumers from buying plans.
Indeed, the latter possibility has been estimated to account for one-fifth of the slowdown in costs (Ryu, et
a!. 2013). All of these scenarios lower costs, but not in a way that prioritizes quality.
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Additionally, during a recession, unemployment tends to spike. As discussed previously, the
majority of Americans receive health insurance through their employers. Correspondently, when there are
fewer jobs, there are fewer health insurance plans, which means depressed utilization of health care
services (Executive Office of the President 20 13).
Backing up this hypothesis, a recent study from the Kaiser Family Foundation created a model
using inflation and GDP growth to estimate the percentage of the slowdown in cost growth that was
attributable to the economy. It concluded that 77% was due to the economic downturn. (Kaiser Family
Foundation 2013).

As a result of the moribund economy, actual utilization of health care services has fallen. The
number of visits to doctors' offices fell4.7% in 2010, and an additional 0.9% in 2012 (Thomas 2012). A
survey by the American Academy of Family Physicians found that 54% of doctors saw a decrease in
patients during the recession, and that 66% of them were taking actions to reduce costs, such moving to
generic prescriptions (Holt 2009). Prescriptions issues dropped 1.1 %, and non-emergency hospital visits
declined 0.5% (Thomas 2012). Some of this reduction is due to greater efficiency, but under-treatment is
also a factor (IMS Institute for Healthcare Informatics 2013). Needless to say, this freeze on prices and
spending will thaw as the economy heats up.
Taking all of this into consideration, it is not unreasonable to assume that the dip in cost inflation
has been an example of an anomaly, not normalcy. It is also worth pointing out that even the
comparatively rate of cost growth of7.5% is still triple general inflation and economic expansion, and
would still outpace projected GDP growth (Torres 2012).
If I am correct that health care costs will begin to return to their prerecession levels, policy
makers would be well served to respond. However, the health care policy landscape has been radically
altered by the passage of the Affordable Care Act, which touches virtually every area of the industry.
Before proposing new policy, I wish to briefly analyze the impacts of the ACA.
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III. The Affordable Care Act
On the near horizon, the health care industry will have to contend with the full implementation of the
Affordable Care Act. Already, numerous provisions of the law have gone into effect. Although the law's
primary focus was not touted as controlling health care costs, in many cases, it targets the wasteful areas
that I have identified and implements strategies to reduce them. Therefore, before I lay out policy
proposals to reduce or control health care spending, it is important to consider what is already being done
so far as to avoid redundant solutions, spot areas that were unaddressed, and to identify promising reforms
that may benefit from expansion.
To be certain, the law will increase spending; not only through the expansion of Medicaid, but
also through subsidies to help low- and moderate-income patients afford care. Indeed, it is projected that
in 2014, when the law is in full effect, government spending will increase 18% for Medicaid, 8.8% for
prescription drugs, and 8.5% for physician services (Walker 2012). As a result, the net increase to the
deficit between 2015 and 2024 is expected to be $1.2 trillion.
With Medicaid, 25 states have opted to expand the program, resulting in a 5% boost in enrollment
in 2014. This has led to $33 billion in additional outlays for the program, an increase of about 12% double the rate of growth in 2013. Taken together, government spending on health care is projected to
totalS.!% ofGDP by 2015, and 6.1% in 2024, surpassing the cost of Social Security. This translates into
an additional $2 trillion in government health care spending over the next decade (CBO 2014).
The law also includes numerous provisions that will actually reduce health care spending. In the
realm of reducing administrative costs, the law has begun the standardization of billing and claims forms
(Novack 2014). This includes uniform electronic standards and operating rules to be used by public, as
well as private, insurance providers. Taken together, this could save the federal government $20 billion
over ten years, in addition to savings realized by the private sector (Orszag and Emanuel201 0).
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The Obama Administration has provided savings estimates for some of these initiatives. The
Partnership for Patients program seeks to reduce hospital complications and reducing preventable injuries
and has a goal of saving about $11.7 billion per year. Anti-fraud efforts undertaken as a result of the ACA
have resulted in about $3.7 per year in recovered payments. However, the White House policy brief does
not estimate savings for many of its programs. I will attempt to.
With the passage of the law, the Prevention and Public Health Fund was established to promote
investments in preventative care. The program works by disbursing grant money to a wide variety of
government agencies, such as the Centers for Disease Control or the Administration for Community
Living, for the purpose of projects. The total cost of all of the programs currently being funded was $750
million in fiscal year 20 11.Examples of these include education campaigns on Alzheimer's treatment,
training for health care providers, and effectiveness research on preventative services (U.S. Department of
Health & Human Services 2013).
It has been estimated that a $2.9 billion investment in public health initiatives such as this would

save $16.5 billion annually (Forsberg and Fichtenberg 2012). Considering that $750 million is a quarter
of $2.9 billion, I will assume that the savings will be one-fourth as great, or $4.1 billion annually. Though
small, this means that every dollar invested would yield five dollars in savings.
Having a greater percentage of primary care physicians in an area, relative to specialists, is
another method to reduce spending, as they are better able to coordinate care between health care
providers (Thornton 2012). Incentives are created by the ACA to encourage primary care physicians and
general surgeons to practice in areas that lack them. To wit, practitioners who move to high-need areas
can receive a 10% bonus under Medicare (Manchikanti, eta!. 2011).
It is estimated that this policy will reduce Medicare spending by 2% (Reschovsky, eta!. 2012).

Given that Medicare costs the government about $536 billion on Medicare, a 2% reduction would result
in nearly $11 billion saved.
24

An oft-mentioned provision of the law relates to Accountable Care Organizations (ACOs). These
are individual health care providers or groups of providers that are eligible to share in savings that are
created when they improve efficiency. Because efficiency of the entire patient process is considered, and
not simply focused on one particular procedure or visit, providers have an incentive to target wasteful
spending holistically by better coordinating care and reducing fragmentation (Executive Office of tbe
President 2013).
A good example of tbe kinds of cost savings tbat these organizations can produce comes from the
Pioneer A COs, a collection of 32 A COs from all across the county representing 669,000 beneficiaries.
Designation as an ACO, and along with it, the financial benefits, is a competitive process conducted by
the Centers for Medicare & Medicaid Services (2012).
hritia1 results from this program are promising. Health care costs for tbe patients emolled in the
Pioneer A COs grew at a rate of 0.3% in 2012, as compared to growth of 0.8% for similar beneficiaries not
emolled in an ACO. This netted a total of$87.6 million, as well as a saving $33 million for the Medicare
Trust Funds. Seeing as only 600,000 people were emolled in this set of ACOs, it is possible that tbe
savings could be much larger if tbe pool were expanded. As an added bonus, health quality indicators
such as cholesterol and blood pressure were also better for patients within an ACO system (Centers for
Medicare & Medicaid Services 2013).
One interesting, if relatively obscure, cost reduction policy deals with hospital readmission rates.
Prior to tbe ACA, hospitals had no incentive to prevent readmission of patients, and between 2007 and
2011, tbe readmission rate within 30 days of discharge remained consistent at 19%. However, the law
began to penalize hospitals with high readmission rates (Executive Office of the President 20 13).

In 2012, the year tbat the penalty took effect, the readmission rate for Medicare patients fell to
18% from 19%, and by 2013, it was at 17.5%. This translates into approximately 70,000 readmissions
during 2012 tban if the rate had remained at 19% (Gerhardt, eta!. 2013). It is estimated that $26 billion is
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spent on Medicare patient readmissions (Lavizzo-Mourey 2013). Given that readmissions rates have
fallen from 19% to 17.5%, an 8% reduction, I estimate that the drop could account for about a $2 billion
decrease in health care spending. If the downward trend continues, the savings could grow.
The law promotes the adoption by health care providers of electronic medical records. Although
difficult to create, electronic records save money over time because they reduce redundancy of
paperwork, and allow doctors to more easily access patient information, reducing the rate of errors. It was
been calculated that the ACA will save $21.9 billion a year from greater use of electronic medical records
(Wik:ler, Basch and Cutler 2012).
Some reforms may never come into fruition. In theory, the law will slow Medicare spending
growth to 3%, far lower than the 8% average seen between 2003 and 2012. However, this projection rests
upon the assumption that there will be a 24% cut to fees paid to physician for services under Medicare
(CBO 2014). Those familiar with congressional politics will know that the body routinely override these
reductions in fees, and have done so as recently as February 2014 (Tozzi 2014). Therefore, it is unlikely
that the estimated $17 billion in potential savings will ever materialize, and I will exclude it from
calculations.
The impact of these cost savings may be greater than the sum of their parts, however. In public
health care reforms, there is what is known as the "spillover" effect. Namely, when the goverrnnent
adopts a cost saving reform, the private insurance sector eventually follows suit. One study suggested that
for every dollar of Medicare savings, private insurers save 55 cents (White and Wu 2013).
As noted previously, some of the reduction in health spending is due the recession. Accordingly,
it is entirely possible that some of the savings yielded by the ACA are partially due to economic
stagnation. Still, it is clear that the ACA will yield considerable savings in the wasteful areas that this
paper is concerned with. If the assumptions I made when estimating savings are valid, as much as $54.4
billion would be saved from reducing unnecessary care. Note that this figure does not consider the
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amount that would be saved from structural changes in the health care system caused by greater
prevalence of insurance coverage.

IV. Policy Alternatives
What then, remains to be done to stem the tide of rising health care costs while addressing the problem of
unnecessary spending? In this section, I shall examine several policy alternatives to ameliorate
inefficiencies in the health care system. Policies will be assessed not only upon the total number of dollars
shaved from the system, but also technical feasibility and political viability, for an idea that succeeds only
on paper is of little help.
Medical Malpractice Insurance

Supporters of changes to malpractice insurance, also known as "tort reform," believe it to be one of the
biggest examples of unnecessary overtreatment in the health care system. But it was conspicuously absent
from the final version of the ACA. This was not from lack of trying. In the 2010 health care summit, a
daylong roundtable including President Obama and congressional leadership on both sides of the aisle
worked through the gritty policy details of the ACA, and the issue of tort reform was broached a dozen
times.
However, after the dust settled and the fmal 2,000+ page bill was published, only six of them
dealt with medical malpractice insurance. The chief policy that remained was not bold: $50 million to
explore alternatives to the liability system- one fifth of the amount requested by the Justice Department
for that task in fiscal year 2012 (Norman 2011).
Defensive medicine is more than a specter. A 2008 survey of Massachusetts doctors found that
the vast majority- 83%- admitted to engaging in defensive medicine. The survey concluded that about a
quarter of tests, procedures, and referrals in the state, and 13% of hospital admissions, were done simply
to foreclose the possibility of litigation (Youn 2012). A separate, nationwide survey yielded similar
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results: 93% of doctors reported practicing defensive medicine, which included unnecessary tests,
diagnostic procedures, and consultation (R. Kelley 2009).
At the same time, there have been a great many proposed reforms for the medical liability system
to deal with the problem. Among them, specialized health courts, greater disclosure of risks, and
incentives for hospitals to apologize and offer remuneration to patients without getting the justice system
involved (Roberti 20 12). But the reform which has gained the most traction, including being introduced
as a law in the House of Representatives, is a cap on damages.
Damage caps vaty on whether they apply to economic (those related to the injury or lost wages),
noneconomic (related to emotional duress), or punitive (assigned to punish wrongdoing, not compensate
the victim) datnages, or all tbree. What unites all of them is the goal of reducing the size of payouts,
which may be as much as 60% lower than states without such laws, translating into lower premiums by
anywhere from 6-25% (Nelson, Morrisey and Kilgore 2007).
So what would the impact of a national policy capping damages? The Congressional Budget
Office analyzed this very question in 2009. At the time, it assumed a cap of $250,000 for noneconomic
damages, and a $500,000 cap on punitive datnages. The report found that it will shrink medical liability
insurance premiums by 10%. The impact would be further atnplified due to the fact that the reform would
reduce unnecessary spending as well. Taken together, the policy would save $41 billion per year, which
would account for 0.5% of health care spending (Ehnendorf2009).
As an added benefit, federal tax receipts would go up. As the CBO explains, many employersponsored health care plans represent nontaxable compensation. Since the reform would lower health care
costs on the private market, it was assumed that firms would be able to increase wages, meaning an influx
of $13 billion in federal payroll taxes. When combined with the $41 billion cut from spending, the policy
could provide $54 billion in annual benefits.
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Using the cost estimates provided by Bovbj erg, tort reform could result in a one percent decline
in spending, equating to about $20 billion in savings during the first year and $260 billion over the first
decade (Bovbjerg 2010). But that is a low-end estimate. An article in Health Affairs calculated it to be
$55 billion annually, 2.4% of total health care spending (Lallemand 2012).
From a policy perspective, a damage cap is also appealing in that it is incredibly simple,
technically speaking. Assuming the law was passed, the only implementation that it would require would
be laying down a bright line rule for courts to follow when adjudicating claims. They would have little, if
any, discretion, to subvert the cap. Similarly, attorneys would not be able to argue over precisely what the
cap means; it would just be a numerical threshold.
Given that many policies are complex, and are much more ambiguous than a cap, there is
typically much more room to stymie the implementation process. A cap would need no rulemaking body
to draft a proposed regulation, and along with it, the necessary public comment and response. Aggrieved
parties would have less of a chance to muddle the rollout process, thus allowing the policy to achieve
maximum effectiveness.
However, the policy is far from perfect. The amount saved from damage caps could be larger than
the CBO assumes, but there are a number of mitigating factors that limit their effectiveness. To begin,
some doctors may not be prescribing unnecessary tests out of fear of liability, but rather because they can
bill for additional tests and procedures (Thornton 20 12). If this is the case, changes in liability insurance
would have no effect on their behavior. Lastly, malpractice premiums may fall, but there is no guarantee
that physicians will pass all of these savings along to patients.
Skeptics of this sort of policies point to the fact that the current state of affairs is not as dire as
reformers claim. To begin, only a small percentage of those injured seek damages, around 4-7%, and a
smaller number succeed (Conover 2012). Few of the lawsuits are "frivolous." Less than 5% of claims are
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minor, temporary injuries or purely emotional. Fatal injuries, the most common cause for litigation, make
up 31% of claims (Gower 2013).
Furthermore, they note that while malpractice claims may be a component of health costs, they
are not the driving force behind it. Specifically, the number of claims filed over the last 30 years has
remained largely static, about one serious iujury per one hundred hospitalizations, whereas the number of
iuteractions between patients and physicians has gone up. Thus, the percentage of patients who are
actually filing claims is decliuiug (Baker 2009).
On top of this, medical malpractice premiums, inflation-adjusted, are at the lowest poiut iu over
30 years. fu the decade between 2000 and 2009, malpractice claims fell by half (Hunter, Cassell-Stiga and
Doroshow 2009). Total payouts nationwide are on a downward trend and have been since 2003 -far
precediug the recession. fu 2012 alone, they fell3.4%, bringing them to the lowest level siuce the late
1990s (Gower 2013).
Not only do critics of tort reform question the necessity of damage caps, they fear that it could
have adverse consequences for patients. Although some, if not most of defensive mediciue does not serve
to improve patient outcomes, one cannot conclude that it is completely without value. Some additional
tests may actually reveal conditions in need of treatment. Simultaneously, doctors may be more cautious
when they know that their own fmances are on the line when they screw up.
Because of these reasons, tort reform may have the unexpected benefit of reducing the quality of
care. According to the fustitute ofMediciue, 98,000 people die each year due to medical malpractice,
meaniug that the U.S. has the third highest rate of deaths from medical error in the world. The creation of
the proposed damages cap could add as many as 4,800 deaths annually (Durbin 20 I 0).
Coming to a similar conclusion, a workiug paper from the National Bureau of Economic
Research (NBER) found that simply decreasing the malpractice premium costs could increase the number
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of patient deaths. Specifically, it found that a 10% decrease in malpractice costs would result in a 0.2%
increase in mortality (Lakdawalla and Seabury 2009).
The NBER study also noted that most conventional estimates of the economic value of a human
life are around $6 million. Using this number, the loss oflife outweighs the reduction in malpractice
premiums. Of course, this is grim way to evaluate a policy; it may well be that legislators would prefer to
place a greater value on human life than is reflected by the numbers.
Regardless of the effectiveness of malpractice reforms, the issue is surrounded by a great deal of
political contention. As noted previously, Republicans fought hard to include some form of tort reform
while the ACA was being debated. Senators Lindsey Graham (R) and Tom Colburn (R) both submitted
amendments to the law. More recently, they introduced the HEALTH Act, which seeks to institute the
same damages cap that was kept out of the original law (Norman 2011).
They are backed up by various think tanks. The U.S. Chamber Institute for Legal Reform, for
instance, is a strong proponent of hard limits on malpractice awards (Young 20 10). It is joined by the
usual consortium of conservative bastions of thought. These include the Heritage Foundation and the
American Enterprise Institute. Interestingly, the Cato Institute, which normally would be in perfect
alignment with these groups, has published a paper opposing federal damage caps, not on policy grounds,
but rather because it says that the federal govermnent does not possess the constitutional authority to
enact them (Krauss 1998).
Democrats have typically met these efforts with skepticism. Senate Majority Whip Dick Durbin
(D-lll.) has been one of the most outspoken opponents of tort reform, stating that it is fundamentally
unfair to deprive victims of damages if the suffering caused by a medical error is substantial (Vance

2010). He is far from alone. Democratic Senators Pat Leahy, Chuck Schumer, and Robert Menendez have
all approached the suggestion of damage caps with caution (Bolton 2011 ).
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That is not to say that there has been no bipartisan talk on the subject. Erskine Bowles and Alan
Simpson, who gained notoriety as the co-chairs of the President's National Commission on Fiscal
Responsibility and Reform, have gone around the country calling for austerity measures. Among them,
they ask for reforming medical malpractice as a means of controlling health care costs (McCarthy 2011 ).
During the debate over ACA, President Obama said that he would at least consider tort reform, but
ultimately left it out of the law. He later clarified to say that he does not favor damage caps, but
acknowledged defensive medicine as a driver of health care spending (Condon 2009).
While this law has only been introduced at the federal level, many states have already imposed
caps. Across the country, these caps vary widely in size, ranging from $200,000 to $750,000, and vary
over what kinds of damages they restrict (Nelson, Morrisey and Kilgore 2007). It is interesting to note the
diversity of states that have imposed these caps. Both liberal California, where the governor's mansion
and both chambers of the legislature are controlled by Democrats, and conservative Texas, where
Republicans control both political branches, have damage caps. fudeed, only fourteen states do not have a
cap (Roberti 2012).
Trial lawyers, who benefit from large victim payouts made possible by the current system, are
strongly opposed to changing the medical liability landscape. The American Association for Justice
(AAJ), a professional organization consisting of plaintiff attorneys, has spent $3.5 million in lobbying in

2012, with over 90% of that sum going to Democratic candidates (Center for Responsive Politics 2012).
The group has long been active in the debate. Back during the presidency of George W. Bush, it defeated
his plans to enact medical liability reforms, and was a key player to keep it out of the Affordable Care Act
(Young 2010).
Not to be outdone, on the other side of the fight, the American Medical Association (AMA), the
largest professional group representing physicians in the country, has come out strongly in support of
damage caps. Considerably larger than the AAJ, the group spent over $16 million lobbying in 2012 alone.
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Although it is more bipartisan in its distribution of funds, it still gives a little under two-thirds of its PAC
money to Republicans (Center for Responsive Politics 2012).
In addition to disagreement within the legislative branch, the judiciary has also weighed in on the

matter. In several jurisdictions, state supreme courts have found damages caps to be unconstitutional
(Nelson, Morrisey and Kilgore 2007). Specifically, the state supreme courts oflilinois and Georgia held
caps to be an improper abrogation of the power of juries to set damages with full discretion. At the same
time, in West Virginia and Alaska, the state high courts upheld the constitutionality of damage caps
(Roberti 2012).
Were a federal law to be subjected to judicial review, it is worth noting that the present
composition of the Supreme Court is a 5-4 conservative tilt, so it is likely that the law would be upheld.
To attempt to glean the Court's reasoning, we may look to past cases that involved similar facts. Back in
1978, the case of Duke Power Company v. Carolina Environmental Study Group, Inc. it was held that
damage caps for injuries from nuclear accidents passed constitutional muster (Roberti 2012). In the 1996
case BMW ofNorth America, Inc. v. Gore, the Court found overly excessive noneconomic damage awards
to be unconstitutional (Tager 1999).
All told, the political climate around medical malpractice is highly charged. This means that it
would likely be difficult to pass in more pragmatic times, but given the current state of division in
Washington, it is doubtful that Democrats and Republicans would be able to come to an agreement on this
policy. Resultantly, this policy alternative may not be the most attractive overall, despite good marks in
technical feasibility.
Price Transparency
The market for health care is an economist's nightmare. Many of the market forces that would militate
against rising prices in other industries simply do not exist for the health care market in the United States.
Sudden injuries and illnesses create demand uncertainty by preventing consumers from planning in
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advance when they will purchase care. Third-party payers distort incentives to reduce costs (Christensen,
Floyd and Maffett 2013). But perhaps most vexing of all, the true cost of most medical services are
obscured, resulting in pricing failures that could be as large as $84-131 billion (Berwick and Hackbarth
2012).
To get an idea of the systematic overpricing of medical procedures, we can look at the average
cost of various medical services in the U.S. as compared to other developed countries. The results show
that American consumers may pay anywhere from double to 26 times the price that a foreigner would
face (Rosenthal2013). For instance, the typical price of anMRI scan in the United States is $1,121, as
compared to $319 in the Netherlands

Figure 11. Comparative Prices for Selected Procedures
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Transparency in health care prices seeks to alleviate these huge disparities in prices. By allowing
consumers to make more informed choices, the hope is that providers will be forced to compete to lower
prices to attract more business (Christensen, Floyd and Maffett 2013). Certainly, price transparency has
been successful at reducing spending in other industries, such as toll roads and electricity (CBO 2008).
There is much need for this sort of information. According to the Vanderbilt Center for EvidenceBased Medicine, 90 million consumers have difficulty understanding their health care options, directly
resulting in a 3 to 6% increase in medical expenditures (Coluni 2012).
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But what is the potential savings to be realized from such a policy in the health care industry? As
stated earlier, an estimated $84-131 billion is wasted annually due to pricing failures (Berwick and
Hackbarth 2012). However, due to all of the distortions present in the health care market, it is doubtful
that any policy could end all inefficiency.
A stndy out of the University of Chicago gives what is perhaps a more realistic assessment. The
focus was on hip replacements, which ranged from $16,000 to $93,000 in price. After controlling several
other confounding variables, the conclusion was that price transparency regulations had an independent,
causal effect on prices, bringing the cost of hip replacements down by 6.5% -a savings of nearly $2,800
to consumers. Additionally, the laws had the effect of tightening the distribution of prices, with the most
expensive hospitals seeing the largest reduction in prices (Christensen, Floyd and Maffett 2013).
The stndy did not provide far reaching estimates for cost reductions, but I wish to extrapolate. Per
capita, $1,650 is spent on physician and clinical services, with about 313 million people in the U.S. Using
these figures, about $516 billion is spent on physician services, which the stndy suggests would be
responsive to price transparency. Were price transparency equally successful in reducing prices across all
procedures across the country, the potential savings would be $33.5 billion.
Unsurprisingly, the study also found that consumers with larger co-pays, and thus more incentive
to reduce costs, saw a greater effect. These consumers had an 11% reduction in services purchased.
Consumers in general were also more likely to switch to cheaper hospitals. At this point, it is important to
highlight the fact that in health care, higher prices do not necessarily indicate higher quality.
An extensive experiment conducted by the RAND Corporation in the 1970s and 1980s found that

when patients spent less on health care, there was little impact on their health (CBO 2008). The fact that
transparency might lead consumers to select lower cost alternatives should not be taken to mean that they
are choosing inferior care. This finding was buttressed by research from the Massachusetts Attorney
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General's Office and the state Division of Health Care Finance and Policy, which found no correlation
between cost and quality (Coluni 20 12).
Although the primary focus of price transparency is to help patients, there may also be benefits
for insurance companies. For this reason, several insurers have worked to start their own price
transparency initiatives (GAO 2011). By having a better understanding ofthe prices, insurers would have
more bargaining power and would be able to better negotiate prices with hospitals (Muir, Alessi and King
2013).
A white paper from Thomson Reuters provides an additional estimate of the potential savings. If
high cost outliers could be brought towards the median price for a given good or service through price
transparency, there could be as much as a 3.5% reduction in spending. This equates to $36 billion in
savings per year- and that only considers employer sponsored health care plans (Coluni 2012). This is
quite similar to the estimate that I calculated.
It must be noted that the policy solution is not as simple as posting the prices online and leaving

market forces to work. The Centers for Medicare and Medicaid Services has already posted the raw data
for hundreds of hospitals, but it is in a form that is not readily accessible to the average patient. It is
important that it be structured in a way that makes the information useful.
Fortunately, we have 30 states to look to for wisdom on how to structure an effective law.
California, for example, required hospitals to make available the list prices for their goods and services.
However there are several key omissions from the requirement. Namely, physician services (such as
surgeries), are not disclosed, and because patients with insurance typically do not pay the full list price,
also called chargemaster price, the information is not entirely relevant to them (CBO 2008).
New Hampshire, which passed a law in 2007, had a more holistic approach. The state's Insurance
Department compiles comprehensive information on physician services, out-of-pocket costs, and total
prices. This principle was reaffirmed in a report from the Government Accountability Office, which noted
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that disclosing negotiated prices, not just chargemaster prices, was key in providing consumer lucid
information. Additionally, patients should be made aware of quality of care so that they may make a fully
informed decision (GAO 201 1). Quality of care information may include mortality rates for procedures,
complication rates, or average length of stay.
Promotion is also critical to the policy's ultimate fate. In California, inadequate public awareness
led to less than a quarter of the population actually being aware that there was any information on hospital
prices at all (Coluni 2012). After instituting a publicity campaign, visits to the transparency website
spiked.
Unfortunately, there may be unintended consequences of transparency as well. In markets with
high concentration and low competition, it is possible that providers would take advantage of
transparency by raising, rather than lowering, prices to match their rivals. At the same time, firms may
have less incentives to cut prices if they know that the move would be matched by other providers,
eroding any competitive advantage they would have had (CBO 2008). However, the CBO report that
raised this concern singled out hospitals as the most susceptible to this sort of collusion, yet, the
aforementioned University of Chicago study centered on hospitals and found that price transparency
resulted in lower, not higher, prices for consumers.
The fear has also been raised that by being upfront with prices, patients may decline to get
necessary treatment, and in the long run, they will be worse off (Rosenbaum 20 13). This argument is not
totally invalid, but it is difficult to say that consumers cannot be trusted with information over the
products that they must ultimately bear the costs of.
Even if the potential pitfalls do not outweigh the benefits, they cannot be ignored. To address
concerns about collusion among health care providers, it is vital that the federal government ramp up its
anti-trust efforts in the event that transparency measures were to pass into law. In New Hampshire, the
first two years of price transparency did not result in a dramatic reduction in costs, but this was partly due
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to the fact in many rural areas of the state, health care providers did not have effective competition.
Furthermore, there was at least some evidence that the law constrained growth rates, and its effectiveness
would only grow the longer it was in effect (Tu and Lauer 2009).
While it is true that the effectiveness of health care transparency is lessened by the fact that
insurance prevents patients from seeing the full cost of care, this may not be a barrier to the success of a
transparency policy in the future. As noted earlier, the share of health insurance plans with deductibles is
increasing. If the trend continues, consumers may become more sensitive to higher prices, increasing the
utility of price transparency.
Another important benefit of the policy is that it enjoys a wealth of political currency. Back in
2010, the House Energy and Commerce Committee heard testimony on three bills relating to price
transparency. Although none of them ultimately made it out of committee due to trepidation over the
ultimate effectiveness of transparency, the bipartisan support behind th= was heartening. Two were
introduced by Republicans, and one by a Democrat. Two of the three had co-sponsors from both sides of
the aisle (Bakhtiari 2010). Paul Ryan, a Republican policy wonk and the Party's nominee for Vice
President in 2012, has written in support of price transparency.
It is also worth recalling that those who were opposed to the price transparency law cited the

2008 CBO report which warned that transparency could lead to collusion. However, four years later, Peter
Orszag, the Director of the CBO during 2008, came out in support of price transparency (2012), noting
that fuller transparency has a necessary component of broad reform.
There is also some agreement among interest groups that often at loggerheads. Unions
representing constituencies as varied as public workers to physicians and nurses, in states from Florida to
California have come out in support of greater price transparency laws. For workers, transparency stands
to make health care more affordable; for physicians, it allows them greater insight as to where costs are
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going (Shinkman 20 14). Employers too have come out in support of price transparency in hopes that it
will lower the cost of providing care (Leavitt 2012).
Because health care transparency, at its core, utilizes private market forces to bring down costs,
the idea is very amenable to conservatives. Thomas Miller, a health policy analyst who has worked for
both the American Enterprise Institute and Cato Institute, and a staunch critic of Obamacare, has endorsed
the policy (2006). The Heritage Foundation expressed openness towards the concept, even though its
support carried the stipulation that transparency would only be effective as part of a larger reform, (Nix
2010).
Left leaning think tanks have also lined up in support of such a policy. The Brookings Institute
has made statements in support of greater transparency law in conjunction with antitrust efforts. The
Center for American Progress calls the reform "common sense." The liberal Economic Policy Institute
has also called for greater transparency in the health care market (Gould 2013).
Of course, support is not universal. Health plan providers may balk at full disclosure, worrying
that the information is proprietary or that they already have preexisting confidentiality agreements.
Perhaps needless to say, if transparency was successful at bringing down costs, they would be losing out
on billions in potential revenue through markup. Similarly, a special interest group representing device
manufacturers -which would stand to lose profits from price transparency- paid for study that concluded
that transparency laws would be harmful (Pauly and Bums 2008).
Transparency will not be a panacea. To recap, there are several specific principles that must be
incorporated into a price transparency policy in order for it to achieve maximum potential effectiveness.
First, the disclosure platform should be user friendly, not merely the raw aggregation of data. Next, it
should include not only sticker price, but also negotiated prices, as well as quality of care information.
Lastly, it must be actively promoted, and done with an eye towards preventing collusion among
providers. Still, it represents a policy that has the potential to lower costs without harming quality of care.
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Administrative Simplification
There is no way to manage the delivery of $2.7 trillion in medical services without some level of
bureaucratic complexity. Quite apart from prescribing medicine and performing surgeries, health care
providers must contend with such myriad tasks as determining patient insurance costs, collecting and
depositing payments, maintaining databases, managing appeals, and negotiating claims, inter alia (Yong
and Olsen 2010).
But the American experience is uniquely onerous, partially explained by the private sector
emphasis of the U.S. health care system (Kelley and Fabius 2010). A little less than half of health care
spending is covered by the govermnent, as compared to a 72% average in other developed countries
(OECD 2012). Putting aside the pluses and minuses of public health care in the aggregate, it has a better
track record on controlling administrative costs. The Institute of Medicine found that private insurers
spent $105 billion on administrative costs in 2009, whereas public insurance programs only spent $42
billion.
It is also worth comparing public and private efficiency in terms of percentages, not just gross

dollars. For private insurers, it is approximated that 12.3% is spent on overhead. For comparison,
Medicaid has between 4-5% spent on administration, and Medicare is only at 2% (Yong and Olsen 201 0).
Short of radically transforming the private-public composition of the American health care
system, what can be done to cut through the red tape? Surely, some of the administrative costs are
necessary to properly monitor care, but what about the estimated 50% of administrative spending that is
wasteful (Wikler, Basch and Cutler 2012)?
One of the hallmarks of health care administration is redundancy. Standardization could be a key
solution in cutting down the complexity and accompanying costs. This remedy has worked in other
industries as well. For example, the Federal Reserve succeeded in lowering administrative costs for banks
by implementing a uniform computer system for financial institutions to cormnunicate with each other.
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Walmart brought costs down by requiring suppliers to use its standard computer format for their retail
information (Cutler, Wikler and Basch 2012).
Could a similar solution work for health care? There have certainly been efforts in the past. The
Health Insurance Portability and Accountability Act (HIP AA) of 1996 did mandate standardization of
electronic processing of common administrative transactions, but the law had sufficient ambiguity that
different payers still had variation in terms of their format, dampening the law's effectiveness.
Furthermore, many firms continued to use manual means to process transactions (Yong and Olsen 201 0).
There has been some progress on this front with the implementation of the Affordable Care Act.
It has required the Department of Health and Human Services (DHHS) to lay down more detailed rules,

and, as noted in the last section, has greatly expanded the use and standardization of electronic medical
records. This includes requiring payers to accept a standard billing form electronically.
However, there are many other areas which the ACA overlooked. Credentialing systems are used
to establish contracts between providers. The average physician must handle nearly 20 different types of
these forms, devoting a total of 23 hours annually across the entire staff. All told, this costs ten-physician
practice $7,600 per year (Ivey 2006). Having a nationwide standard could greatly simplify the process for
doctors.
There are many other examples. Reporting requirements for quality and safety programs differ
between the various plans, public and private. Many steps in the administration process could be
automated. Standardized enrollment across different public health care programs would reduce headache
for patients (Wikler, Basch and Cutler 2012).
It is difficult to give one cost savings estimate for simplification due to the fact that most policy

papers given numerous recommendations of areas that could be standardized. Individually, each reform
would only save a few billion dollars. Summed up, a paper from the Center for American Progress
pegged the savings of six separate realms of administrative simplification at $35.7-45.8 billion. However,
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$21.9 billion of that is from reforms from the ACA that are already in progress. Thus, the savings from
new. reforms would be $13.8-23.9 billion.
Additional research from the Institute of Medicine examined simplifying the process by which
physicians interact with payers. In physician practices, $64.7 billion is spent on administrative costs
collectively. Standardization of payer-physician interactions, using a model similar to Canada, costs
would fall by 10%, a savings of $6.5 billion. Total savings may be greater, as it does not factor in the time
savings to physicians and staff.
Hence, if we sum the collective simplification reform proposals, we get an estimated savings of
$20.3-30.4 billion. In addition to cost savings, simplification may yield other benefits as well. By making
the system more efficient, consumers would experience fewer delays and issues receiving care.
Physicians and their supporting staffs would have more time available for patients. In short, it would
make it easier for the health care system to focus on health.
Case in point, a Minnesota law that standardized the electronic exchange of health care
transactions was projected to save the state $60 million (Kelley and Fabius 2010). When prior
authorization for medical tests was automated within the state, the number of unnecessary tests fell, as did
the time spent interacting with plans.
Ironically, the task of simplifying the health care system may be extremely complex. Because
there are so many different types of forms for so many different interactions, there is no one national
standard that could be used. Rather, a common format would have to be established for a variety of forms.
This would involve reconciling many different providers to bring them all to the same page. Given the
decentralized nature of the U.S. health care system, this would be a formidable task.
As an additional roadblock, the organ of govermnent that would be in charge of creating and
enforcing these standards is not entirely clear (Kelley and Fabius 2010). Such an undertaking may even
require a new office within the DHHS specifically tasked with putting out rules and implementing them
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(Cutler, Wilder and Basch 2012). This would open the door to all of the complications that are inherent in
the rulemaking process. To make matters worse, multiple rules would have to be executed, forcing
regulators to run the gauntlet of public comment again and again. As evidenced by the limited success of
HIPPA, agencies may face significant difficulty in achieving true reforms.
To be sure, the solution of administrative simplification is as popular as motherhood and apple
pie. Members of every political party have been able to join hands in opposition to wasteful overhead
spending. A survey of the health care platforms from the major American political parties revealed that
they are united by the common refrain of simplifying the system. On the left, the Democratic Party
pledges to root out waste from health care. On the right, the Republican Party spoke out against the
bureaucracy in the system.
Indeed, it is difficult to conceive of any politician coming out in favor of bureaucratic hassle.
There are no think tanks publishing paper on how to throw more dollars down the drain. No policy briefs
are written advocating for ever more cumbersome paperwork.
Even the health care industry itself is in support of cutting red tape. In 2008, the American
Medical Association published a white paper outlining solutions to cut down on administrative waste. As
the earlier figures about wasted time and resources spent on negotiating the bureaucratic system illustrate,
physicians would stand to gain much from simplification.
In the abstract, no one could possibly be opposed to pairing down "administrative complexity."
The true divisions come out when one tries to define exactly what is wasteful. For instance, the
Affordable Care Act provides federal funds for "navigators" to help patients work their way through the
options available to them (Caper 2013). In a sense, this is health care spending that does not go to actual
patient care, and thus, is overhead. But supporters of the ACA would quickly note the importance of this
expenditure, and balk at the proposition that this is needless waste.
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There are countless other examples. Does profit that a firm earns count as an administrative cost?
Advertising? Bill collection? fuvestigations into fraud? Perhaps. All of these things have been counted in
various estimates {Klein 2009). But whether or not these functions are worthy expenses is a much harder
question to answer than whether we should reduce "administrative complexity."
Similarly, proponents of a single payer health care system often note that it could save hundreds
of billions of dollars by sheering down complexity alone- far more than the policies that I have
identified. Of course, such an overhaul of the health care system would make the debates over the
enactroent of the ACA look tame by comparison.
That said, in politics, optics matter a great deal. fu public opinion polling, a solid majority- 65%
-reported that they would be in favor of federal action to ameliorate administrative expenses (Oberlander
and White 2009). The fact that the idea, at least on the surface, has such broad public appeal, it would
make it easier to get the policy off the methodical runway. Additionally, I believe that the specific areas
that I have identified would generally be considered unnecessary by most serious players.

V.

Policy Recommendation

Before making a policy recommendation, there are three factors that I will consider. The first is the most
straightforward: estimated savings. This figure is determined based on the studies done on each of the
policy alternatives. There may be some variation among estimates, but I have attempted to come up with
a reasonable number. I provided a range of cost reduction estimates in an attempt to convey that it is
difficult to determine the exact savings that a policy will yield.
The second factor is political difficulty. There is no simple measure of the political obstacles that
a given policy would face, and given today's polarized Congress, any bill would have difficult time
becoming law. That said, to assess the political odds of each policy, I considered statements by prominent
Democrats and Republicans, positions of various ideological think tanks, the intensity of interest group
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involvement in the policy area- both for and against- and actions that state governments took. No
method is perfect, but I feel as if my final ratings are fair.
The only policy that I looked at that is hotly contested is medical malpractice reform. Any law
with a damage cap would face strenuous opposition. The other two policies, by and large, would be
relatively uncontroversial. Granted, some special interest groups would protest, but such acts would pale
in comparison to a hot issue.
The third factor is technical feasibility. This is perhaps the vaguest of all the categories. To
determine the technical feasibility, I took into account not only the difficulty of writing a law that would
fully capture the scope of the policy solution, but also the effort that would be taken to implement it.
A damage cap would be straightforward: the law would be passed, and courts would apply the
cap. Price transparency would be more complex, as it would require not only publishing the information,
but also making it accessible to consumers, and complemented by anti-trust enforcement. Administrative
standardization would require not only the design of common forms that covered all pertinent
information, but possibly the creation of a new agency to design them.
After assessing these three categories, I conclude the price transparency would be the best policy
alternative. The savings that it could yield are in the mid-range, however, the variation between the
estimates is tight, and lower range is the highest of the three policies. Furthermore, the cuts in spending
would come out of the profit sheets of hospitals and device manufacturers, not injured patients, as with
damage caps.
Both price transparency and administrative simplification both are popular concepts. Price
transparency is not demonstrability better than standardization, but when taken in conjunction with the
technical feasibility, it comes out on top.
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Figure 12. Policy Alternative Evaluations
Policy Alternative

Estimated Savings

Political Difficulty

Technical Difficulty

Liability Damage Caps

$20-55 billion

High

Low

Price Transparency

$33.5-36 billion

Low

Medium

Administrative Standardization

$13.8-23.9 billion

Low

High

fu terms of complexity, I would place price transparency as only medium. Although there would

be numerous challenges to creating the policy, much of the groundwork has already been done. The
Centers for Medicare and Medicaid Services already publishes a vast amount of data on hospital costs.
Although it is not easily accessible to patients, the raw numbers exist.
Back in 2010, H.R. 4803 was introduced, mandating price and quality transparency. A less
ambitious H.R. 5800 was introduced in 2012. Both of these bills acted through amending Title XIX of the
Social Security Act, and both of them are less than one thousand words long. This would provide
legislators with model legislation, a legal mechanism, and an indication that even a more comprehensive
law would not need to be incredibly verbose.
Anti-trust regulators would need to be vigilant if a price transparency law was enacted, but this is
hardly an untested muscle of the federal government. It has performed this function for over 100 years
across every industry imaginable. Originally, railroads and oil companies may have the principle target of
anti-trust laws, but, more recently, Amazon was successfully charged by the Department of Justice for
fixing prices on its e-books (Molina 2014).
Specifically to health care, the Federal Trade Connnission (FTC), working with the Department
of Justice, is already active in policing anti-competitive behavior. There have already been cases filed
against medical device suppliers, pharmaceutical companies, and hospitals for monopolistic practices.
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Although state governments may also be involved, it is clear that the federal government is already
involved in pursuing health care anti-trust cases, so, there may be no need for new enforcement laws.
At this point, I would like to perform a basic cost-benefit analysis of the policy. In order to
provide as safe an analysis as possible, I will use very conservative estimates for benefits and very liberal
estimates for costs. First, let me expound upon the benefits.
The lower estimate for savings is $33.5 billion. Alluding back to the analysis of a damage cap, the
CBO found that it would increase wages, and thus federal tax receipts. By the CEO's count, every dollar
shaved from health care costs, there would be an increase of 30 cents in tax revenue. I will assume that
every dollar in health care spending reduced will increase revenue by 15 cents. Even by this more modest
estimate, $5 billion in revenue would be generated.
Moving on to costs, the total budget of the Antitrust Division of the Department of Justice is $163
million, and the FTC spends roughly $25 million on "promoting competition" through stopping collusion.
Thus, about $200 million is spent on enforcing anti-trust policy on the part of the federal government. Of
course, only a fraction of this is actually spent on health care, but in encompass all possible costs, and
costs to state governments, ·I will assume that an additional $200 million will be spent.
There would need to be some sort of web interface to store and access price and quality
information. No one has estimated what this will cost, but I will look at the cost of the ACA website.
Certainly, Healthcare.gov would be much larger than a price transparency website, but it is at least an
example of a government sponsored health care websites. Cost estimates for Healthcare.gov vary, but its
staunchest critics claim $350 million (Kessler 2013), so that is the figure I will use.
Therefore, total benefits could be approximately $38.5 billion, and total costs of the policy could
be as great as $550 million. Thus, the net benefit would be just a little under $38 billion. Over the course
of a decade, this could equate to $380 billion in savings.
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Lastly, I will discount the savings to give an idea of the present value of the savings. This is will
provide a more accurate estimate of the long-term savings, rather than just multiplying the savings in one
year by ten. The formula that I will use is as follows:

T(1 -

(1 ~on) where B is benefits, i is the interest rate, and n is the number of years.

In this example, B is $38 billion, i is 2% which is roughly the interest rate on a ten-year Treasury
securities, (Federal Reserve 2014), adjusted for inflation, and n is 10. Plugging in these numbers, we get:
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bil
0.02

(1 -

1

(1 +0.02)10

) =

$340 billion

Hence, I estimate that if a comprehensive price transparency policy were enacted, even
accounting for the costs of implementing and enforcing it, it would still have hundreds of billions of
dollars over the decade. To put that in perspective, $30 billion a year could pay for universal pre-K across
the nation, eradicate world hunger, or simply reduce the federal deficit by a fair amount

Taken in totality, I believe that price transparency is the strongest policy alternative available. It
would likely produce a sizable savings in the health care system, past transparency bills have had
bipartisan support, and it would be solution that would not require creation of a large bureaucracy to
execute. Indeed, even when using pessimistic assumptions, the benefits still outweighed the costs.

VI. Conclusion
The problem of health care cost inflation is particularly vexing. It is too large to be ignored. Any way that
it is measured, health care costs are on the rise. Left unabated, they run the risk of draining the federal
budget, hamstringing the economy, and impoverishing consumers and businesses alike.
At the same time, the issue is extremely complex. Covering one-sixth of the economy, and
spanning the public and private sector alike, the health care industry brings together millions of
employees in the form of physicians, nurses, clerical and custodial staff, insurers, and many more. They
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are employed in hospitals, practices, and firms large and small. No person within the country is untouched
by the health care system, and it often intimately involved the very beginning and end and our lives.
There are a wide range of factors that drive the growth of health care costs. Some of them are
inexorable, and some of them are good for society. Throughout all of them there is a great deal of waste.
Clearly, no one policy can ever hope to be a silver bullet. Even if all three of my policies were adopted,
and all of their benefits were accrued, it would amount to about $100 billion out of$1 trillion in waste.
Although I believe that policy outlined would be an important step forward, reform will need to be
ongoing.
But more important than implementing my recommended solution would be having policymakers
focus on reducing unnecessary spending in the system. A 2008 survey examined what consumers
believed to be the largest impediments to reducing inefficiency in the health care system
(PricewaterhouseCoopers 2008). Over a dozen options were available to them, including political
gridlock, sheer complexity, and a culture unresponsive to change. But the most common response, given
by nearly half of all respondents, was that it was not a priority of the U.S. goverrunent. It is time to
change that.
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